Ontology highlight
ABSTRACT:
PROVIDER: PRJNA657265 | ENA |
REPOSITORIES: ENA
Similar Datasets
Project description:Transcription profiling by high throughput sequencing of the potato (genotype RH89-039-16) ArrayExpress Release Date: 2011-07-11 Person Roles: submitter Person Last Name: Soenderkaer Person First Name: Mads Person Mid Initials: Person Email: mson@bio.aau.dk Person Phone: 4530532492 Person Address: Sohngaardsholmsvej 49, 9000 Aalborg, Denmark Person Affiliation: Aalborg University
2011-07-14 | GSE30615 | GEO
Project description:Transcriptome Analysis of the potato (genotype RH89-039-16). To aid annotation and address a series of biological questions, we generated RNA-Seq data from 16 RH libraries representing all major tissue types, developmental stages and responses to abiotic and biotic stresses.
2012-02-16 | E-MTAB-552 | biostudies-arrayexpress
Project description:Solanum tuberosum strain:RH89-039-16 Raw sequence reads
| PRJNA335820 | ENA
Project description:Transcriptome Analysis of the potato (genotype RH89-039-16)
| PRJEB2430 | ENA
Project description:Alternate haplotype of a heterozygous diploid potato RH89-039-16
| PRJNA646008 | ENA
Project description:Transcription profiling by high throughput sequencing of different potato tissues (genotype RH89-039-16)
2016-09-23 | E-MTAB-552 | ExpressionAtlas
Project description:[E-MTAB-552] Transcriptome Analysis of the potato (genotype RH89-039-16)
| PRJNA144525 | ENA
Project description:SMCs express plasminogen activator inhibitor-1 (PAI-1), which regulates SMC function and vascular remodeling. However, whether PAI-1 controls SMC cytoskeletal dynamics and stiffness is unknown, and the causal role of PAI-1 in arterial stiffening is undefined. SMCs from human coronary arteries and aortae of wild-type vs. PAI-1-deficient mice were cultured with or without PAI-039, a specific PAI-1 inhibitor, after which cell stiffness was measured by atomic force microscopy, filamentous actin structures were assessed by confocal microscopy, and the activities cofilin, LIM domain kinase 1 (LIMK), slingshot homolog 1 (SSH), and AMP-activated protein kinase (AMPK) were measured. RNA sequencing was performed to determine the effects of PAI-039 on SMC gene expression. Effects of PAI-039 on aortic stiffness were assessed by pulse wave velocity. PAI-039 significantly reduced intrinsic stiffness of human SMCs, which was accompanied by significant decreases in cytoplasmic actin filaments. Similar effects were observed in wild-type, but not in PAI-1-deficient SMCs. Mechanistically, PAI-039 significantly increased the activity of cofilin, an actin depolymerase, in SMCs expressing PAI-1, but not in PAI-1-deficient cells. PAI-039 had no significant effects on LIMK or SSH activity. RNA-sequencing analysis suggested that PAI-039 up-regulates AMPK signaling in SMCs, which was confirmed by western blotting. Inhibition of AMPK prevented activation of cofilin by PAI-039. In mice, PAI-039 significantly decreased aortic stiffness without significantly altering peri-aortic fibrosis. PAI-039 decreases intrinsic SMC stiffness by reducing cytoplasmic stress fiber content. These effects are mediated by AMPK-dependent activation of cofilin. PAI-039 also decreases aortic stiffness in vivo. These findings suggest that PAI-1 is an important regulator of the SMC cytoskeleton and that pharmacologic inhibition of PAI-1 has potential to treat cardiovascular diseases mediated by accelerated arterial stiffening.
2023-02-23 | GSE225644 | GEO
Project description:FIT-039 is a novel antiviral compound. Antiviral mechanism of FIT-039 is the inhibition of the viral transcription through suppression of the CTD phosphorylation of RNA polymerase II. We used microarrays to evaluated the effect of FIT-039 on host cellular transcriptome, compared with Flavopiridol which is an existing pan-specific CDK9 inhibitor.
2014-07-08 | GSE57429 | GEO